DrugPatentWatch Database Preview
Investigational Drug Information for Bavituximab
Email this page to a colleague
What is the drug development status for Bavituximab?
Bavituximab is an investigational drug.
There have been 26 clinical trials for Bavituximab.
The most recent clinical trial was a Phase 3 trial, which was initiated on December 1st 2013.
The most common disease conditions in clinical trials are Carcinoma, Non-Small-Cell Lung, Breast Neoplasms, and Carcinoma. The leading clinical trial sponsors are Peregrine Pharmaceuticals, University of Texas Southwestern Medical Center, and National Comprehensive Cancer Network.
There are thirty-seven US patents protecting this investigational drug and eight hundred and sixty-six international patents.
Summary for Bavituximab
| US Patents | 37 |
| International Patents | 866 |
| US Patent Applications | 0 |
| WIPO Patent Applications | 0 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2013-12-01) |
| Vendors | 0 |
Recent Clinical Trials for Bavituximab
| Title | Sponsor | Phase |
|---|---|---|
| 1922GCCC: Pembro and Bavituximab for Squamous Cell Carcinoma of Head and Neck | University of Maryland, Baltimore | Phase 2 |
| An Open Label Study of Bavituximab and Pembrolizumab in Advanced Gastric and GEJ Cancer Patients | Merck Sharp & Dohme Corp. | Phase 2 |
| An Open Label Study of Bavituximab and Pembrolizumab in Advanced Gastric and GEJ Cancer Patients | Oncologie Inc. | Phase 2 |
Clinical Trial Summary for Bavituximab
Top disease conditions for Bavituximab
Top clinical trial sponsors for Bavituximab
US Patents for Bavituximab
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Bavituximab | ⤷ Try it Free | Multispecific constructs | AbbVie Stemcentrx LLC (North Chicago, IL) | ⤷ Try it Free |
| Bavituximab | ⤷ Try it Free | .beta.-glucan methods and compositions that affect the tumor microenvironment | BIOTHERA, INC. (Eagan, MN) | ⤷ Try it Free |
| Bavituximab | ⤷ Try it Free | Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein | CureVac AG (Tubingen, DE) | ⤷ Try it Free |
| Bavituximab | ⤷ Try it Free | Method of treating pancreatic cancer | ChemoCentryx, Inc. (Mountain View, CA) | ⤷ Try it Free |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Bavituximab
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Bavituximab | Canada | CA2900764 | 2033-02-08 | ⤷ Try it Free |
| Bavituximab | European Patent Office | EP2954056 | 2033-02-08 | ⤷ Try it Free |
| Bavituximab | Hong Kong | HK1218930 | 2033-02-08 | ⤷ Try it Free |
| Bavituximab | Japan | JP2016509014 | 2033-02-08 | ⤷ Try it Free |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
